BioOrbit raised €11M in a Seed round in Apr 2026. The company is based in London, UK. Investors in the round: 7 percent, Auxxo, Breega and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.